BeLiver
My visitor profile
BeLiver
Description of your activity
- At BeLiver, we increase the chances of beating liver cancer by selecting the most suitable treatment for each patient. We are developing a personalized test platform that reveals a tumor’s unique biology, allowing us to predict the probability of treatment response. Using proteomics and AI, in less than one week, we can deliver a detailed report, outlining the likelihood of success for immunotherapies and chemotherapies.
More information
- To date, we have conducted two POC in liver cancer involving more than 70 patients, successfully distinguishing responders from non-responders for both first- and second-line treatments. Building on these promising results, we are now collaborating with seven French hospitals to expand our research and validate our test for the upcoming first line of treatment.
Emerging company
Madeleine MOSCATELLI
CEO
Date of your company creation:
- Less than 1 year
Main sector
- Biotechnology - Therapeutics and Diagnostics, Medical device or technology
Address
- Country : FRANCE
- City : Bordeaux
- Zip Code : 33000
Participation objectives
Partnering objectives
- Financing / investment opportunities, Human resources opportunities, Network development